Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 31, 2020

SELL
$61.62 - $67.78 $308,100 - $338,900
-5,000 Closed
0 $0
Q1 2019

May 01, 2019

SELL
$62.53 - $70.05 $62,530 - $70,050
-1,000 Reduced 16.67%
5,000 $325,000
Q2 2018

Jul 30, 2018

BUY
$64.88 - $75.68 $64,879 - $75,680
1,000 Added 20.0%
6,000 $425,000
Q1 2018

Apr 30, 2018

SELL
$72.84 - $88.8 $145,680 - $177,600
-2,000 Reduced 28.57%
5,000 $377,000
Q4 2017

Feb 06, 2018

BUY
$71.15 - $83.52 $142,300 - $167,040
2,000 Added 40.0%
7,000 $501,000
Q3 2017

Oct 25, 2017

BUY
$72.11 - $85.47 $360,550 - $427,350
5,000
5,000 $405,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track New Jersey Better Educational Savings Trust Portfolio

Follow New Jersey Better Educational Savings Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Jersey Better Educational Savings Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Jersey Better Educational Savings Trust with notifications on news.